[Clinical trial of polychemotherapy of inoperable bronchopulmonary cancers].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001389:Azirines / Q000627:therapeutic use; D001984:Bronchial Neoplasms / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004357:Drug Synergism; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D008175:Lung Neoplasms / Q000188:drug therapy*; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D014747:Vinblastine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D001389:Azirines; D006834:Hydrazines; D014747:Vinblastine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D005472:Fluorouracil; D008727:Methotrexate
Essai clinique de polychimiothérapie des cancers broncho-pulmonaires inopérables.